|
  - Expands treatment information for all diagnoses.
Provides more illustrations, many in full color, and expands the figure legends. Features color-coded chapters and an improved index for quick reference.
- Includes two new appendices: a history and examination primer and a drug guide.
With more than 15 additional contributing experts. |
|
|
1 | (25) |
|
|
|
1 | (5) |
|
|
|
1 | (4) |
|
|
|
1 | (1) |
|
Orbital hemorrhage or orbital compartment syndrome, |
|
|
1 | (2) |
|
|
|
3 | (2) |
|
|
|
5 | (2) |
|
|
|
5 | (1) |
|
Intraorbital foreign body, |
|
|
5 | (1) |
|
Carotid-cavernous fistula, |
|
|
6 | (1) |
|
|
|
7 | (4) |
|
|
|
7 | (2) |
|
|
|
9 | (2) |
|
|
|
11 | (4) |
|
Thyroid-related ophthalmopathy, |
|
|
11 | (2) |
|
Idiopathic orbital inflammation or orbital pseudotumor, |
|
|
13 | (2) |
|
|
|
15 | (1) |
|
|
|
15 | (1) |
|
|
|
15 | (1) |
|
|
|
15 | (1) |
|
Pediatric orbital tumors, |
|
|
15 | (3) |
|
Benign pediatric orbital tumors, |
|
|
15 | (2) |
|
Orbital dermoid or dermoid cyst, |
|
|
15 | (1) |
|
|
|
16 | (1) |
|
Juvenile xanthogranuloma, |
|
|
17 | (1) |
|
Malignant pediatric orbital tumors, |
|
|
17 | (1) |
|
|
|
17 | (1) |
|
|
|
18 | (1) |
|
|
|
18 | (1) |
|
|
|
18 | (5) |
|
Benign adult orbital tumors, |
|
|
18 | (3) |
|
|
|
18 | (1) |
|
|
|
19 | (1) |
|
Neurilemmoma or schwannoma, |
|
|
19 | (1) |
|
|
|
20 | (1) |
|
|
|
20 | (1) |
|
|
|
21 | (1) |
|
|
|
21 | (1) |
|
Malignant adult orbital tumors, |
|
|
21 | (3) |
|
|
|
21 | (2) |
|
|
|
23 | (1) |
|
|
|
23 | (1) |
|
|
|
23 | (1) |
|
Atrophia bulbi and phthisis bulbi, |
|
|
24 | (2) |
|
Atrophia bulbi without shrinkage, |
|
|
24 | (1) |
|
Atrophia bulbi with shrinkage, |
|
|
25 | (1) |
|
Atrophia bulbi with disorganization or phthisis bulbi, |
|
|
25 | (1) |
|
2 OCULAR MOTILITY AND CRANIAL NERVES, |
|
|
26 | (29) |
|
|
|
26 | (2) |
|
|
|
28 | (2) |
|
|
|
28 | (2) |
|
|
|
28 | (1) |
|
|
|
29 | (1) |
|
Acquired nonaccommodative esotropia and other forms of esotropia, |
|
|
29 | (1) |
|
|
|
30 | (1) |
|
|
|
30 | (2) |
|
|
|
31 | (1) |
|
Convergence insufficiency, |
|
|
31 | (1) |
|
|
|
31 | (1) |
|
|
|
31 | (1) |
|
|
|
32 | (1) |
|
|
|
32 | (1) |
|
|
|
32 | (1) |
|
|
|
32 | (1) |
|
|
|
33 | (2) |
|
|
|
33 | (1) |
|
Dissociated strabismus complex: dissociated vertical deviation or dissociated horizontal deviation, |
|
|
34 | (1) |
|
Monocular elevation deficiency, |
|
|
34 | (1) |
|
|
|
35 | (1) |
|
Miscellaneous strabismus, |
|
|
35 | (1) |
|
Duane's retraction syndrome, |
|
|
35 | (1) |
|
|
|
35 | (1) |
|
|
|
36 | (1) |
|
|
|
36 | (3) |
|
|
|
36 | (1) |
|
|
|
37 | (1) |
|
|
|
38 | (1) |
|
Third cranial nerve palsy, |
|
|
39 | (2) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
40 | (1) |
|
|
|
40 | (1) |
|
|
|
40 | (1) |
|
Fourth cranial nerve palsy, |
|
|
41 | (3) |
|
|
|
42 | (1) |
|
|
|
42 | (1) |
|
|
|
42 | (1) |
|
|
|
42 | (2) |
|
Sixth cranial nerve palsy, |
|
|
44 | (2) |
|
|
|
44 | (1) |
|
|
|
44 | (1) |
|
|
|
44 | (1) |
|
|
|
44 | (1) |
|
|
|
45 | (1) |
|
Multiple cranial nerve palsies, |
|
|
46 | (2) |
|
|
|
46 | (1) |
|
|
|
46 | (1) |
|
Cavernous sinus syndrome, |
|
|
46 | (1) |
|
|
|
47 | (1) |
|
Chronic progressive external ophthalmoplegia, |
|
|
48 | (2) |
|
Kearns-Sayre syndrome (mitochondrial DNA), |
|
|
48 | (1) |
|
MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke), |
|
|
48 | (1) |
|
MERRF (myoclonus epilepsy with ragged red fibers), |
|
|
48 | (1) |
|
|
|
48 | (1) |
|
Oculopharyngeal muscular dystrophy (AD), |
|
|
48 | (2) |
|
|
|
50 | (1) |
|
Internuclear ophthalmoplegia (INO), |
|
|
50 | (1) |
|
|
|
50 | (1) |
|
|
|
51 | (1) |
|
Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome), |
|
|
51 | (1) |
|
Dorsal midbrain (Parinaud's syndrome), |
|
|
51 | (1) |
|
Progressive supranuclear palsy, |
|
|
51 | (1) |
|
Dorsal midbrain syndrome, |
|
|
52 | (1) |
|
|
|
52 | (3) |
|
3 LIDS, LASHES, AND LACRIMAL GLANDS, |
|
|
55 | (56) |
|
|
|
55 | (3) |
|
|
|
55 | (1) |
|
|
|
56 | (1) |
|
|
|
56 | (1) |
|
|
|
56 | (1) |
|
|
|
56 | (2) |
|
|
|
58 | (5) |
|
Blepharitis and meibomitis, |
|
|
58 | (2) |
|
|
|
60 | (1) |
|
|
|
60 | (1) |
|
|
|
61 | (1) |
|
|
|
62 | (1) |
|
Phthiriasis or pediculosis, |
|
|
62 | (1) |
|
|
|
62 | (1) |
|
|
|
63 | (5) |
|
Chalazion or hordeolum, (stye), |
|
|
63 | (1) |
|
|
|
64 | (2) |
|
|
|
66 | (1) |
|
|
|
66 | (1) |
|
|
|
66 | (1) |
|
|
|
67 | (1) |
|
|
|
68 | (8) |
|
|
|
68 | (3) |
|
Aponeurotic (involutional), |
|
|
69 | (1) |
|
|
|
69 | (1) |
|
|
|
69 | (1) |
|
|
|
69 | (1) |
|
|
|
70 | (1) |
|
|
|
71 | (1) |
|
|
|
72 | (2) |
|
|
|
72 | (1) |
|
|
|
72 | (1) |
|
|
|
72 | (1) |
|
|
|
72 | (1) |
|
|
|
72 | (1) |
|
|
|
72 | (2) |
|
|
|
74 | (2) |
|
|
|
74 | (1) |
|
|
|
74 | (1) |
|
|
|
74 | (1) |
|
|
|
74 | (2) |
|
|
|
76 | (1) |
|
|
|
76 | (1) |
|
|
|
76 | (1) |
|
|
|
77 | (2) |
|
|
|
79 | (1) |
|
|
|
80 | (2) |
|
Congenital eyelid anomalies, |
|
|
82 | (4) |
|
|
|
82 | (1) |
|
|
|
82 | (1) |
|
|
|
82 | (1) |
|
|
|
83 | (1) |
|
|
|
83 | (1) |
|
|
|
84 | (1) |
|
|
|
84 | (1) |
|
|
|
85 | (1) |
|
|
|
85 | (1) |
|
|
|
85 | (1) |
|
|
|
86 | (6) |
|
Pigmented benign eyelid tumors, |
|
|
86 | (3) |
|
|
|
86 | (1) |
|
|
|
87 | (1) |
|
Nevus of Ota (oculodermal melanocytosis), |
|
|
87 | (1) |
|
|
|
88 | (1) |
|
|
|
88 | (1) |
|
Verruca vulgaris (viral papilloma), |
|
|
89 | (1) |
|
Nonpigmented benign eyelid tumors, |
|
|
89 | (2) |
|
|
|
89 | (1) |
|
Moll's gland cyst (hidrocystoma, sudoriferous cyst), |
|
|
90 | (1) |
|
Epidermal inclusion cyst, |
|
|
90 | (1) |
|
Inverted follicular keratosis, |
|
|
90 | (1) |
|
|
|
90 | (1) |
|
|
|
90 | (1) |
|
Pilomatrixoma (calcifying epithelioma of Malherbe), |
|
|
90 | (1) |
|
Vascular benign eyelid tumors, |
|
|
91 | (1) |
|
|
|
91 | (1) |
|
|
|
91 | (1) |
|
Port wine stain (nevus flammeus), |
|
|
92 | (1) |
|
|
|
92 | (6) |
|
|
|
92 | (1) |
|
|
|
93 | (1) |
|
|
|
93 | (1) |
|
|
|
94 | (1) |
|
Sebaceous cell carcinoma, |
|
|
94 | (1) |
|
|
|
95 | (1) |
|
|
|
96 | (1) |
|
|
|
97 | (1) |
|
Kaposi's sarcoma of the eyelid, |
|
|
97 | (1) |
|
|
|
98 | (3) |
|
|
|
98 | (2) |
|
|
|
100 | (1) |
|
|
|
100 | (1) |
|
|
|
101 | (2) |
|
|
|
103 | (1) |
|
Nasolacrimal duct obstruction, |
|
|
104 | (2) |
|
|
|
106 | (2) |
|
|
|
108 | (3) |
|
Benign mixed cell tumor (pleomorphic adenoma), |
|
|
108 | (1) |
|
Malignant mixed cell tumor (pleomorphic adenocarcinoma), |
|
|
109 | (1) |
|
Adenoid cystic carcinoma (cylindroma), |
|
|
109 | (2) |
|
4 CONJUNCTIVA AND SCLERA, |
|
|
111 | (38) |
|
|
|
111 | (3) |
|
|
|
111 | (1) |
|
|
|
111 | (1) |
|
|
|
112 | (1) |
|
Subconjunctival hemorrhage, |
|
|
113 | (1) |
|
|
|
114 | (1) |
|
|
|
115 | (1) |
|
|
|
116 | (2) |
|
Decreased tear production, |
|
|
116 | (1) |
|
Increased tear evaporation, |
|
|
116 | (2) |
|
|
|
118 | (4) |
|
|
|
119 | (1) |
|
|
|
119 | (1) |
|
|
|
119 | (1) |
|
|
|
119 | (1) |
|
|
|
120 | (1) |
|
|
|
120 | (1) |
|
|
|
120 | (2) |
|
|
|
122 | (1) |
|
|
|
122 | (3) |
|
|
|
122 | (1) |
|
|
|
122 | (1) |
|
|
|
122 | (1) |
|
|
|
122 | (1) |
|
|
|
123 | (1) |
|
|
|
123 | (1) |
|
|
|
124 | (1) |
|
|
|
124 | (1) |
|
Atopic keratoconjunctivitis (AKC), |
|
|
124 | (1) |
|
Vernal keratoconjunctivitis (VKC), |
|
|
124 | (1) |
|
|
|
124 | (1) |
|
|
|
125 | (4) |
|
|
|
125 | (1) |
|
|
|
125 | (1) |
|
|
|
125 | (1) |
|
|
|
125 | (1) |
|
Giant papillary conjunctivitis, |
|
|
125 | (1) |
|
|
|
126 | (1) |
|
|
|
126 | (3) |
|
Superior limbic keratoconjunctivitis, |
|
|
126 | (1) |
|
|
|
126 | (1) |
|
|
|
127 | (1) |
|
Parinaud's oculoglandular syndrome, |
|
|
127 | (1) |
|
|
|
127 | (2) |
|
Conjunctival degeneration, |
|
|
129 | (3) |
|
|
|
130 | (1) |
|
|
|
130 | (1) |
|
|
|
131 | (1) |
|
|
|
131 | (1) |
|
Ocular cicatricial pemphigoid, |
|
|
132 | (2) |
|
Stevens-Johnson syndrome or erythema multiforme major, |
|
|
134 | (1) |
|
|
|
135 | (8) |
|
|
|
135 | (1) |
|
|
|
135 | (1) |
|
|
|
135 | (1) |
|
|
|
136 | (1) |
|
|
|
136 | (1) |
|
|
|
136 | (1) |
|
Conjunctival intraepithelial neoplasia, |
|
|
137 | (1) |
|
|
|
137 | (1) |
|
|
|
137 | (3) |
|
|
|
137 | (1) |
|
|
|
138 | (1) |
|
Oculodermal melanocytosis or nevus of Ota, |
|
|
138 | (1) |
|
Primary acquired melanosis (PAM), |
|
|
138 | (1) |
|
Secondary acquired melanosis, |
|
|
139 | (1) |
|
|
|
139 | (1) |
|
|
|
140 | (2) |
|
|
|
140 | (1) |
|
Juvenile xanthogranuloma, |
|
|
140 | (1) |
|
|
|
141 | (1) |
|
|
|
141 | (1) |
|
|
|
141 | (1) |
|
|
|
142 | (1) |
|
|
|
142 | (1) |
|
|
|
143 | (1) |
|
|
|
144 | (2) |
|
|
|
146 | (3) |
|
Alkaptonuria or ochronosis, |
|
|
146 | (1) |
|
|
|
147 | (1) |
|
|
|
147 | (1) |
|
|
|
147 | (1) |
|
|
|
147 | (2) |
|
|
|
149 | (54) |
|
|
|
149 | (4) |
|
|
|
149 | (1) |
|
Chemical or thermal burn, |
|
|
149 | (1) |
|
|
|
150 | (1) |
|
|
|
151 | (1) |
|
|
|
152 | (1) |
|
|
|
153 | (1) |
|
Peripheral ulcerative keratitis, |
|
|
153 | (2) |
|
|
|
153 | (1) |
|
|
|
153 | (2) |
|
Contact lens-related problems, |
|
|
155 | (6) |
|
|
|
155 | (1) |
|
|
|
156 | (1) |
|
|
|
157 | (1) |
|
|
|
157 | (1) |
|
Contact lens-related dendritic keratitis, |
|
|
157 | (1) |
|
Contact lens solution hypersensitivity or toxicity, |
|
|
158 | (1) |
|
Corneal neovascularization, |
|
|
158 | (1) |
|
|
|
158 | (1) |
|
|
|
159 | (1) |
|
Deposits on contact lens, |
|
|
159 | (1) |
|
Giant papillary conjunctivitis, |
|
|
159 | (1) |
|
|
|
160 | (1) |
|
Sterile corneal infiltrates, |
|
|
160 | (1) |
|
|
|
160 | (1) |
|
|
|
160 | (1) |
|
Superior limbic keratoconjunctivitis, |
|
|
160 | (1) |
|
Superficial punctate keratitis, |
|
|
160 | (1) |
|
|
|
161 | (4) |
|
|
|
161 | (1) |
|
|
|
161 | (1) |
|
|
|
162 | (1) |
|
|
|
162 | (1) |
|
Superficial punctuate keratitis, |
|
|
163 | (1) |
|
Thygeson's superficial punctuate keratitis, |
|
|
163 | (2) |
|
|
|
165 | (1) |
|
Graft rejection or failure, |
|
|
166 | (2) |
|
Infectious keratitis (corneal ulcer), |
|
|
168 | (7) |
|
|
|
168 | (1) |
|
|
|
169 | (1) |
|
|
|
170 | (1) |
|
|
|
171 | (4) |
|
|
|
175 | (2) |
|
|
|
177 | (1) |
|
|
|
178 | (4) |
|
|
|
178 | (1) |
|
|
|
179 | (1) |
|
|
|
179 | (1) |
|
|
|
180 | (1) |
|
|
|
180 | (1) |
|
Spheoidal degeneration (actinic, Labrador keratopathy, Bietti's nodular dystrophy), |
|
|
180 | (1) |
|
Salzmann's nodular degeneration, |
|
|
181 | (1) |
|
Terrien's marginal degeneration, |
|
|
181 | (1) |
|
White limbal girdle of Vogt, |
|
|
,181 | |
|
|
|
182 | (3) |
|
|
|
182 | (1) |
|
|
|
183 | (1) |
|
Pellucid marginal degeneration, |
|
|
183 | (2) |
|
|
|
185 | (3) |
|
Cornea plana (autosomal dominant [AD] or autosomal recessive [AR]), |
|
|
185 | (1) |
|
|
|
185 | (1) |
|
|
|
186 | (1) |
|
|
|
186 | (1) |
|
|
|
186 | (1) |
|
|
|
187 | (1) |
|
|
|
187 | (1) |
|
|
|
188 | (7) |
|
Anterior (epithelial and Bowman's tnembrane), |
|
|
,188 | |
|
Anterior basement membrane (ABMD) (epithelial basement membrane [EBMD], nnap-dot-fingerprint [MDF], (ogan's microcystic) (AD), |
|
|
188 | (1) |
|
(Gelatinous droplike (AR), |
|
|
188 | (1) |
|
|
|
189 | (1) |
|
|
|
189 | (1) |
|
|
|
190 | (2) |
|
|
|
190 | (1) |
|
Central cloudy (François) (AD), |
|
|
190 | (1) |
|
Central crystalline (Schnyder's) (AD), |
|
|
190 | (1) |
|
Congenital hereditary stromal (CHSD) (AD), |
|
|
191 | (1) |
|
Fleck (François-Neetans') (AD), |
|
|
191 | (1) |
|
|
|
191 | (1) |
|
|
|
191 | (1) |
|
|
|
192 | (1) |
|
Pre-Descemet's (deep filiform) (Al)), |
|
|
192 | (1) |
|
|
|
192 | (4) |
|
Congenital hereditary endothelial (CHED) (AR > AD), |
|
|
192 | (1) |
|
|
|
193 | (1) |
|
Posterior polymorphous (PPMD) (AD), |
|
|
193 | (2) |
|
|
|
195 | (1) |
|
|
|
196 | (3) |
|
|
|
196 | (1) |
|
|
|
196 | (1) |
|
|
|
196 | (1) |
|
|
|
197 | (1) |
|
Immunoglobulin (multiple myeloma), |
|
|
197 | (1) |
|
|
|
197 | (1) |
|
Lipid or cholesterol (dyslipoproteinemias), |
|
|
198 | (1) |
|
|
|
198 | (1) |
|
|
|
198 | (1) |
|
|
|
198 | (1) |
|
|
|
198 | (1) |
|
|
|
199 | (1) |
|
|
|
200 | (3) |
|
|
|
203 | (20) |
|
|
|
203 | (4) |
|
Primary angle-closure glaucoma, |
|
|
203 | (2) |
|
Secondary angle-closure glaucoma, |
|
|
205 | (2) |
|
|
|
207 | (1) |
|
|
|
208 | (2) |
|
Anterior chamber cells and flare, |
|
|
210 | (1) |
|
|
|
211 | (2) |
|
|
|
213 | (3) |
|
|
|
213 | (1) |
|
|
|
213 | (1) |
|
|
|
213 | (3) |
|
Anterior uveitis (iritis, iridocyclitis), |
|
|
216 | (6) |
|
Infectious anterior uveitis, |
|
|
216 | (1) |
|
Noninfectious anterior uveitis, |
|
|
216 | (1) |
|
Nongranulomatous noninfectious anterior uveitis, |
|
|
216 | (3) |
|
Granulomatous noninfectious anterior uveitis, |
|
|
219 | (3) |
|
Uveitis-glaucoma-hyphema syndrome, |
|
|
222 | (1) |
|
|
|
223 | (33) |
|
|
|
223 | (2) |
|
|
|
223 | (1) |
|
|
|
224 | (1) |
|
|
|
224 | (1) |
|
|
|
224 | (1) |
|
|
|
225 | (1) |
|
|
|
226 | (2) |
|
Peripheral anterior synechiae (PAS), |
|
|
228 | (1) |
|
|
|
229 | (1) |
|
|
|
230 | (1) |
|
Pigment dispersion syndrome, |
|
|
231 | (2) |
|
|
|
233 | (1) |
|
|
|
234 | (2) |
|
|
|
234 | (1) |
|
|
|
234 | (1) |
|
|
|
234 | (1) |
|
|
|
235 | (1) |
|
|
|
236 | (2) |
|
Greater anisocoria in dark (abnormal pupil is smaller), |
|
|
236 | (1) |
|
Greater anisocoria in light (abnormal pupil is larger), |
|
|
236 | (1) |
|
Anisocoria equal in light and dark, |
|
|
236 | (2) |
|
|
|
238 | (1) |
|
|
|
239 | (1) |
|
|
|
240 | (2) |
|
|
|
240 | (1) |
|
|
|
240 | (1) |
|
|
|
240 | (2) |
|
Relative afferent pupillary defect (RAPD, Marcus Gunn pupil), |
|
|
242 | (1) |
|
|
|
243 | (1) |
|
|
|
244 | (2) |
|
|
|
244 | (1) |
|
|
|
245 | (1) |
|
Persistent pupillary membrane, |
|
|
245 | (1) |
|
Plateau iris (configuration or syndrome), |
|
|
245 | (1) |
|
Mesodermal dysgenesis syndromes, |
|
|
246 | (3) |
|
|
|
247 | (1) |
|
|
|
247 | (1) |
|
|
|
247 | (1) |
|
|
|
247 | (1) |
|
|
|
247 | (2) |
|
Iridocorneal endothelial (ICE) syndromes, |
|
|
249 | (2) |
|
Essential iris atrophy (progressive iris atrophy), |
|
|
249 | (1) |
|
|
|
250 | (1) |
|
Iris nevus (Cogan-Reese) syndrome, |
|
|
250 | (1) |
|
|
|
251 | (2) |
|
|
|
251 | (1) |
|
|
|
252 | (1) |
|
|
|
253 | (1) |
|
Iris pigment epithelium tumors, |
|
|
254 | (1) |
|
Juvenile xanthogranuloma, |
|
|
254 | (1) |
|
|
|
254 | (1) |
|
|
|
255 | (1) |
|
|
|
256 | (27) |
|
|
|
256 | (3) |
|
|
|
256 | (1) |
|
|
|
257 | (1) |
|
|
|
258 | (1) |
|
|
|
258 | (1) |
|
|
|
258 | (1) |
|
|
|
259 | (4) |
|
|
|
259 | (1) |
|
|
|
259 | (1) |
|
|
|
259 | (1) |
|
|
|
260 | (1) |
|
|
|
260 | (1) |
|
|
|
261 | (1) |
|
|
|
261 | (1) |
|
|
|
261 | (1) |
|
|
|
262 | (1) |
|
|
|
262 | (1) |
|
|
|
263 | (6) |
|
|
|
263 | (1) |
|
|
|
264 | (1) |
|
|
|
265 | (1) |
|
|
|
266 | (1) |
|
|
|
267 | (1) |
|
|
|
267 | (1) |
|
|
|
268 | (1) |
|
Posterior capsular opacification (secondary cataract), |
|
|
269 | (2) |
|
|
|
271 | (1) |
|
|
|
272 | (1) |
|
|
|
273 | (1) |
|
Pseudoexfoliation syndrome, |
|
|
274 | (1) |
|
Pseudoexfoliation glaucoma, |
|
|
275 | (2) |
|
Lens-induced secondary glaucoma, |
|
|
277 | (2) |
|
|
|
277 | (1) |
|
|
|
277 | (1) |
|
|
|
278 | (1) |
|
Dislocated lens (ectopia lentis), |
|
|
279 | (4) |
|
Ectopia lentis et pupillae (AR), |
|
|
280 | (1) |
|
|
|
280 | (1) |
|
|
|
280 | (1) |
|
|
|
280 | (1) |
|
|
|
280 | (1) |
|
Simple ectopia lentis (AD), |
|
|
281 | (1) |
|
Sulfite oxidase deficiency (AR), |
|
|
281 | (1) |
|
|
|
281 | (2) |
|
|
|
283 | (6) |
|
|
|
283 | (1) |
|
|
|
284 | (1) |
|
Persistent hyperplastic primary vitreous |
|
|
284 | (1) |
|
Posterior vitreous detachment |
|
|
285 | (2) |
|
|
|
287 | (2) |
| 10 RETINA AND CHOROID, |
|
289 | (135) |
|
|
|
290 | (2) |
|
|
|
290 | (1) |
|
Commotio retinae (Berlin's edema) |
|
|
290 | (1) |
|
|
|
290 | (1) |
|
|
|
291 | (1) |
|
|
|
292 | (2) |
|
|
|
292 | (1) |
|
|
|
292 | (2) |
|
|
|
294 | (1) |
|
|
|
294 | (1) |
|
Branch retinal artery occlusion (BRAO) |
|
|
294 | (2) |
|
Central retinal artery occlusion (CRAO), |
|
|
296 | (3) |
|
Ophthalmic artery occlusion, |
|
|
299 | (2) |
|
Branch retinal vein occlusion (BRVO), |
|
|
301 | (2) |
|
Central/hemiretinal vein occlusion (CRVO/HRVO), |
|
|
303 | (3) |
|
Venous stasis retinopathy, |
|
|
306 | (1) |
|
Ocular ischemic syndrome, |
|
|
307 | (1) |
|
Retinopathy of prematurity (ROP), |
|
|
308 | (3) |
|
Coats' disease/Leber's miliary aneurysms, |
|
|
311 | (1) |
|
|
|
312 | (1) |
|
Idiopathic juxtafoveal retinal telangiectasia (JXT), |
|
|
313 | (1) |
|
Type 1 A (unilateral congenital parafoveal telangiectasia), |
|
|
313 | (1) |
|
Type 1 B (unilateral idiopathic parafoveal telangiectasia), |
|
|
313 | (1) |
|
Type 2 (bilateral acquired parafoveal telangiectasia), |
|
|
313 | (1) |
|
Type 3 (bilateral perifoveal telangiectasis with capillary obliteration), |
|
|
314 | (1) |
|
Retinopathies associated with blood abnormalities, |
|
|
314 | (3) |
|
|
|
314 | (1) |
|
|
|
315 | (1) |
|
|
|
316 | (1) |
|
Diabetic retinopathy (DR), |
|
|
317 | (5) |
|
Insulin-dependent diabetes (IDDM; type I), |
|
|
317 | (1) |
|
Non-insulin-dependent diabetes (NIDDM; type II), |
|
|
317 | (1) |
|
Nonproliferative diabetic retinopathy (NPDR), |
|
|
318 | (1) |
|
Proliferative diabetic retinopathy (PDR), |
|
|
319 | (3) |
|
Hypertensive retinopathy, |
|
|
322 | (2) |
|
|
|
324 | (1) |
|
Acquired retinal arterial macroaneurysm (RAM), |
|
|
324 | (1) |
|
|
|
325 | (2) |
|
Age-related macular degeneration (AMD), |
|
|
327 | (5) |
|
Nonexudative (dry) macular degeneration, |
|
|
327 | (2) |
|
Exudative (wet) macular degeneration, |
|
|
329 | (3) |
|
Myopic degeneration/pathologic myopia, |
|
|
332 | (1) |
|
|
|
333 | (2) |
|
Central serous chorioretinopathy (CSR)/idiopathic central serous choroidopathy (ICSC), |
|
|
335 | (2) |
|
Cystoid macular edema (CME), |
|
|
337 | (2) |
|
|
|
339 | (3) |
|
Epiretinal membrane/macular pucker, |
|
|
342 | (1) |
|
|
|
343 | (1) |
|
Solar/photic retinopathy, |
|
|
344 | (1) |
|
Toxic/drug maculopathies, |
|
|
344 | (3) |
|
Aminoglycosides (gentamicin, tobramycin, amikacin), |
|
|
344 | (1) |
|
|
|
345 | (1) |
|
Chloroquine (Aralen)/hydroxychloroquine (Plaquenil), |
|
|
345 | (1) |
|
|
|
346 | (1) |
|
|
|
346 | (1) |
|
|
|
346 | (1) |
|
|
|
347 | (1) |
|
|
|
347 | (1) |
|
Farber's disease (lipogranulomatosis) (autosomal recessive [AR]), |
|
|
347 | (1) |
|
Mucolipidosis (mucopolysacchari doses) (AR), |
|
|
348 | (1) |
|
Niemann-Pick disease (AR), |
|
|
348 | (1) |
|
Sandhoff's disease (gangliosidosis type II) (AR), |
|
|
348 | (1) |
|
Tay-Sachs Disease (gangliosidosis type I) (AR), |
|
|
348 | (1) |
|
Peripheral retinal degenerations, |
|
|
348 | (2) |
|
|
|
348 | (1) |
|
Paving stone/cobblestone degeneration, |
|
|
349 | (1) |
|
Peripheral cystoid degeneration, |
|
|
350 | (1) |
|
Snail track degeneration, |
|
|
350 | (1) |
|
|
|
350 | (2) |
|
|
|
352 | (4) |
|
Rhegmatogenous retinal detachment (RRD), |
|
|
352 | (2) |
|
Serous/exudative retinal detachment (SRD), |
|
|
354 | (1) |
|
Traction retinal detachment (TRD), |
|
|
355 | (1) |
|
|
|
356 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
Proliferative vitreoretinopathy (PVR), |
|
|
357 | (1) |
|
Intermediate uveitis/pars planitis, |
|
|
358 | (2) |
|
Neuroretinitis/Leber's idiopathic stellate neuroretinitis, |
|
|
360 | (2) |
|
Posterior uveitis: infections, |
|
|
362 | (12) |
|
Acute retinal necrosis (ARN), |
|
|
362 | (1) |
|
|
|
363 | (1) |
|
|
|
363 | (1) |
|
|
|
364 | (3) |
|
Diffuse unilateral subacute neuroretinitis (DUSN), 366 |
|
|
|
Human immunodeficiency virus (HIV), |
|
|
367 | (1) |
|
Pneumocystis carinii choroidopathy, |
|
|
367 | (1) |
|
Presumed ocular histoplasmosis syndrome (PONS), |
|
|
368 | (1) |
|
Progressive outer retinal necrosis syndrome (PORN), |
|
|
369 | (1) |
|
|
|
370 | (1) |
|
Syphilis (luetic chorioretinitis), |
|
|
370 | (1) |
|
|
|
371 | (1) |
|
|
|
372 | (1) |
|
|
|
373 | (1) |
|
Posterior uveitis: white dot syndromes, |
|
|
374 | (5) |
|
Acute macular neuroretinopathy, |
|
|
374 | (1) |
|
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE), |
|
|
374 | (1) |
|
Acute retinal pigment epitheliitis/Krill's disease, |
|
|
375 | (1) |
|
Birdshot choroidopathy/vitiliginous chorioretinitis, |
|
|
375 | (1) |
|
Multifocal choroiditis and panuveitis (MCP)/subretinal fibrosis and uveitis syndrome, |
|
|
376 | (1) |
|
Punctate inner choroidopathy, |
|
|
376 | (2) |
|
Multiple evanescent white dot syndrome (MEWDS), |
|
|
378 | (1) |
|
Acute idiopathic blind spot enlargement syndrome (AIBSE), |
|
|
378 | (1) |
|
Posterior uveitis: other inflammatory disorders, |
|
|
379 | (8) |
|
|
|
379 | (1) |
|
Idiopathic uveal effusion syndrome, |
|
|
380 | (1) |
|
|
|
381 | (1) |
|
|
|
381 | (2) |
|
|
|
383 | (1) |
|
Serpiginous choroidopathy/geographic helicoid peripapillary choroidopathy (GHPC), |
|
|
384 | (1) |
|
Sympathetic ophthalmia (SO), |
|
|
385 | (1) |
|
Vogt-Koyanagi-Harada syndrome (VKH)/Harada's disease, |
|
|
386 | (1) |
|
Posterior uveitis evaluation/management, |
|
|
387 | (1) |
|
Hereditary chorioretinal dystrophies, |
|
|
388 | (6) |
|
Central areolar choroidal dystrophy (AD), |
|
|
388 | (1) |
|
Choroideremia (X-linked), |
|
|
389 | (1) |
|
Congenital stationary night blindness (CSNE), |
|
|
390 | (2) |
|
Crystalline retinopathy of Bietti (AR), |
|
|
392 | (1) |
|
|
|
392 | (1) |
|
Progressive cone dystrophy (AD>AR>X-linked), |
|
|
393 | (1) |
|
Rod monochromatism (achromatopsia) (AR), |
|
|
394 | (1) |
|
Hereditary macular dystrophies, 394 |
|
|
|
Adult foveomacular vitelliform dystrophy (AD), |
|
|
394 | (1) |
|
|
|
394 | (2) |
|
Butterfly pattern dystrophy (AD), |
|
|
396 | (1) |
|
Dominant drusen/Doyne's honeycomb dystrophy/malattia leventinese (AD), |
|
|
397 | (1) |
|
North Carolina macular dystrophy (Lefler-Wadsworth-Sidbury dystrophy) (AD), |
|
|
397 | (1) |
|
Pseudominflammatory macular dystrophy (Sorshy's) (AD), |
|
|
398 | (1) |
|
Sjogren reticular pigment dystrophy (AR) |
|
|
398 | (1) |
|
Stargardt's disease/fundus flavimaculatus (AR>AD), |
|
|
398 | (1) |
|
Hereditary vitreoretinal degenerations |
|
|
399 | (3) |
|
Familial exudative vitreoretinopathy (FEVR) (AD), |
|
|
399 | (1) |
|
Enhanced S-cone syndrome/Goldmann-Favre syndrome (AR), |
|
|
400 | (1) |
|
Snowflake degeneration (AD), |
|
|
401 | (1) |
|
Wagner/Jansen/Stickler er vitreoretinal dystrophies (AD), |
|
|
401 | (1) |
|
Leber's congenital amaurosis (AR), |
|
|
402 | (1) |
|
|
|
403 | (5) |
|
|
|
403 | (1) |
|
Retinitis pigmentosa inversus, |
|
|
403 | (1) |
|
Retinitis pigmentosa sine pigmentosa, |
|
|
403 | (1) |
|
Retinitis punctata albescens (AR), |
|
|
403 | (1) |
|
Sector retinitis pigmentosa, |
|
|
403 | (1) |
|
Forms associated with systemic abnormalities, |
|
|
403 | (5) |
|
Abetalipoproteinemia (Bassen Kornzweig syndrome), |
|
|
403 | (1) |
|
|
|
404 | (1) |
|
|
|
404 | (1) |
|
Kearns-Sayre syndrome (AR), |
|
|
404 | (1) |
|
Laurence-MoonBardet-Biedl syndromes (AR), |
|
|
404 | (1) |
|
Neuronal ceroid lipofuscinosis (Batten disease), |
|
|
405 | (1) |
|
|
|
405 | (1) |
|
|
|
405 | (3) |
|
|
|
408 | (1) |
|
Ocular albinism (X-linked/AR), |
|
|
408 | (1) |
|
Oculucutaneous albinism (AR>AD), |
|
|
408 | (1) |
|
|
|
409 | (3) |
|
Angiomatosis retinae (von Hippel-Lindau disease) (AD), |
|
|
409 | (1) |
|
Ataxia telangiectasia (Louis-Bar syndrome) (AR), |
|
|
409 | (1) |
|
Encephalotrigeminal angiomatosis (Sturge-Weber syndrome), |
|
|
410 | (1) |
|
Neurulïhromatosis (von Recklinghausen's disease) (AD) |
|
|
410 | (1) |
|
Racemose hemangiomatosis (Wyburn-Mason syndrome), |
|
|
411 | (1) |
|
Tuberous sclerosis (Bourneville's disease) (AD), |
|
|
411 | (1) |
|
|
|
412 | (10) |
|
|
|
412 | (3) |
|
|
|
412 | (2) |
|
|
|
414 | (1) |
|
|
|
414 | (1) |
|
|
|
415 | (3) |
|
|
|
415 | (1) |
|
|
|
415 | (1) |
|
|
|
416 | (1) |
|
Congenital hypertrophy of the retinal pigment epithelium (CHRPE), |
|
|
416 | (1) |
|
|
|
417 | (1) |
|
Combined hamartoma of retinal pigment epithelium and retina, |
|
|
417 | (1) |
|
|
|
418 | (4) |
|
Choroidal malignant melanoma, |
|
|
418 | (2) |
|
|
|
420 | (1) |
|
Primary intraocular lymphoma (reticulum cell sarcoma), |
|
|
421 | (1) |
|
|
|
421 | (1) |
|
Paraneoplastic syndromes, |
|
|
422 | (2) |
|
Bilateral diffuse uveal melanocytic proliferation syndrome (BDUMPS), |
|
|
422 | (1) |
|
Carcinoma-associated retinopathy (CAR), |
|
|
422 | (1) |
|
Cutaneous melanoma-associated retinopathy (MAR), |
|
|
423 | (1) |
| 11 OPTIC NERVE AND GLAUCOMA, |
|
424 | (31) |
|
|
|
424 | (1) |
|
Idiopathic intracranial hypertension (pseudotumor cerebri), |
|
|
425 | (2) |
|
|
|
427 | (2) |
|
|
|
427 | (1) |
|
|
|
427 | (1) |
|
|
|
427 | (2) |
|
Anterior ischemic optic neuropathy, |
|
|
429 | (2) |
|
|
|
429 | (1) |
|
Nonarteritic or idiopathic, |
|
|
429 | (2) |
|
Traumatic optic neuropathy, |
|
|
431 | (2) |
|
Other optic neuropathies, |
|
|
433 | (2) |
|
|
|
433 | (1) |
|
|
|
433 | (1) |
|
|
|
434 | (1) |
|
|
|
434 | (1) |
|
|
|
435 | (5) |
|
|
|
436 | (1) |
|
|
|
436 | (4) |
|
|
|
436 | (1) |
|
|
|
436 | (1) |
|
|
|
437 | (1) |
|
|
|
437 | (1) |
|
|
|
437 | (1) |
|
Septo-optic dysplasia (De Morsier), |
|
|
438 | (1) |
|
|
|
438 | (2) |
|
|
|
440 | (3) |
|
Angioma (von Hippel lesion), |
|
|
440 | (1) |
|
|
|
440 | (1) |
|
Combined hamartoma of retina and retinal pigment epithelium, |
|
|
440 | (1) |
|
|
|
440 | (1) |
|
|
|
440 | (1) |
|
|
|
441 | (2) |
|
|
|
443 | (1) |
|
|
|
444 | (2) |
|
Primary open-angle glaucoma, |
|
|
446 | (3) |
|
Elevated intraocular pressure, |
|
|
446 | (1) |
|
Optic nerve damage (various theories), |
|
|
446 | (3) |
|
Secondary open-angle glaucoma, |
|
|
449 | (4) |
|
Drug-induced secondary glaucoma, |
|
|
449 | (1) |
|
Intraocular tumor secondary glaucoma, |
|
|
450 | (1) |
|
Uveitic secondary glaucoma, |
|
|
451 | (1) |
|
Traumatic secondary glaucoma, |
|
|
451 | (2) |
|
Normal (low) tension glaucoma, |
|
|
453 | (2) |
| 12 VISUAL ACUITY, REFRACTIVE PROCEDURES, AND SUDDEN VISION LOSS, |
|
455 | (24) |
|
|
|
455 | (3) |
|
|
|
455 | (1) |
|
|
|
455 | (1) |
|
|
|
455 | (2) |
|
|
|
457 | (1) |
|
Hyperopia ("farsightedness"), |
|
|
457 | (1) |
|
Myopia ("nearsightedness"), |
|
|
457 | (1) |
|
|
|
457 | (1) |
|
Intraocular refractive procedures, |
|
|
458 | (1) |
|
|
|
458 | (1) |
|
|
|
458 | (1) |
|
Corneal refractive procedures, |
|
|
459 | (2) |
|
|
|
459 | (1) |
|
|
|
459 | (1) |
|
Astigmatic keratotomy (AK), |
|
|
459 | (2) |
|
Automated lamellar keratoplasty (ALK), |
|
|
461 | (1) |
|
|
|
461 | (4) |
|
Laser in situ keratomileusis (LASIK), |
|
|
461 | (3) |
|
Laser-assisted subepithelial keratectomy (LASEK), |
|
|
464 | (1) |
|
Photorefractive keratectomy (PRK), |
|
|
464 | (1) |
|
|
|
465 | (1) |
|
|
|
465 | (1) |
|
Intrastomal corneal ring segments (ICRS, INTACS), |
|
|
465 | (1) |
|
|
|
466 | (1) |
|
Conductive thermokeratoplasty (CK), |
|
|
466 | (1) |
|
Laser thermokeratoplasty (LTK), |
|
|
466 | (1) |
|
Evaluation and management of corneal refractive procedure complications, |
|
|
467 | (1) |
|
Vertebrobasilar artery insufficiency, |
|
|
468 | (1) |
|
|
|
469 | (2) |
|
Classic migraine (10-20%), |
|
|
469 | (1) |
|
Common migraine (70-80%), |
|
|
469 | (1) |
|
|
|
470 | (1) |
|
|
|
470 | (1) |
|
Convergence insufficiency, |
|
|
471 | (1) |
|
|
|
472 | (1) |
|
Functional visual loss (malingering, hysteria), |
|
|
473 | (1) |
|
|
|
473 | (1) |
|
|
|
473 | (1) |
|
Transient visual loss (amaurosis fugax), |
|
|
474 | (1) |
|
|
|
475 | (2) |
|
|
|
475 | (1) |
|
|
|
475 | (1) |
|
|
|
475 | (1) |
|
|
|
476 | (1) |
|
|
|
476 | (1) |
|
Cortical blindness (cortical visual impairment), |
|
|
477 | (2) |
| APPENDIX, |
|
479 | |
|
Ophthalmic history and examination, |
|
|
479 | (12) |
|
|
|
479 | (1) |
|
|
|
479 | (13) |
|
|
|
479 | (2) |
|
|
|
481 | (1) |
|
|
|
482 | (1) |
|
|
|
483 | (1) |
|
|
|
484 | (1) |
|
Corneal light reflex tests, |
|
|
485 | (1) |
|
|
|
485 | (1) |
|
|
|
485 | (1) |
|
|
|
485 | (1) |
|
|
|
486 | (1) |
|
|
|
486 | (2) |
|
Slit lamp examination (SLE), |
|
|
488 | (1) |
|
|
|
489 | (1) |
|
|
|
489 | (2) |
|
AAO suggested routine eye examination guidelines, |
|
|
491 | (1) |
|
Common ophthalmic medications, |
|
|
492 | (6) |
|
|
|
492 | (2) |
|
|
|
492 | (1) |
|
|
|
492 | (1) |
|
Penicullins/synthetic penicillins, |
|
|
492 | (1) |
|
|
|
492 | (1) |
|
|
|
493 | (1) |
|
|
|
493 | (1) |
|
|
|
493 | (1) |
|
|
|
493 | (1) |
|
Antibiotic/steroid combinations, |
|
|
493 | (1) |
|
|
|
493 | (1) |
|
|
|
494 | (1) |
|
|
|
494 | (1) |
|
Miscellaneous antibiotics, |
|
|
494 | (1) |
|
|
|
494 | (1) |
|
|
|
494 | (1) |
|
|
|
495 | (1) |
|
|
|
495 | (1) |
|
Ocular hypotensive (glaucoma) medications, |
|
|
495 | (1) |
|
α-Adrenergic receptor agonists (purple cap), |
|
|
495 | (1) |
|
β-Blockers (yellow or blue cap), |
|
|
495 | (1) |
|
Cholinergic agonists (green cap), |
|
|
496 | (1) |
|
Carbonic anhydrase inhibitors (orange cap), |
|
|
496 | (1) |
|
Prostaglandin analogues (turquoise/teal cap), |
|
|
496 | (1) |
|
|
|
496 | (1) |
|
|
|
496 | (1) |
|
|
|
497 | (1) |
|
|
|
497 | (1) |
|
|
|
497 | (1) |
|
Artificial tear gel formulations, |
|
|
498 | (1) |
|
Artificial tear solution formulations, |
|
|
498 | (1) |
|
Color codes for topical ocular medication caps, |
|
|
498 | (1) |
|
List of important ocular measurements, |
|
|
499 | (1) |
|
|
|
500 | (2) |
|
Common ophthalmic abbreviations, |
|
|
502 | (3) |
|
|
|
505 | (2) |
|
|
|
507 | |
|
|